112 related articles for article (PubMed ID: 10779220)
1. Molecular mechanisms for the growth factor action of gastrin.
Todisco A
J Gastroenterol; 2000; 35 Suppl 12():57-64. PubMed ID: 10779220
[No Abstract] [Full Text] [Related]
2. [Cell cycle and carcinogenesis].
Solé Balcells F
Ann Urol (Paris); 1995; 29(5):271-9. PubMed ID: 8638907
[TBL] [Abstract][Full Text] [Related]
3. Oncogenes, growth factors, and prognostic indicators in colorectal cancer.
Rowley S; Newbold M; Neoptolemos JP
Surg Annu; 1992; 24 Pt 2():59-85. PubMed ID: 1440150
[No Abstract] [Full Text] [Related]
4. Platelet-derived growth factor and autocrine mechanisms of oncogenic processes.
Heldin CH; Westermark B
Crit Rev Oncog; 1991; 2(2):109-24. PubMed ID: 1649642
[No Abstract] [Full Text] [Related]
5. [Endogenous and exogenous factors in tumor development and cell differentiation in gastrointestinal tumors].
Dippold W
Z Gastroenterol; 1993 Jan; 31(1):24-7. PubMed ID: 8447151
[TBL] [Abstract][Full Text] [Related]
6. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.
Smith LL; Coller HA; Roberts JM
Nat Cell Biol; 2003 May; 5(5):474-9. PubMed ID: 12717449
[TBL] [Abstract][Full Text] [Related]
7. Growth regulation in carcinoid tumors.
Ahlman H; Wängberg B; Nilsson O
Endocrinol Metab Clin North Am; 1993 Dec; 22(4):889-915. PubMed ID: 8125077
[TBL] [Abstract][Full Text] [Related]
8. [The EGF receptor and stomach cancer].
Piontek M; Hengels KJ
Z Gastroenterol; 1993 Nov; 31 Suppl 5():18-20. PubMed ID: 8197793
[No Abstract] [Full Text] [Related]
9. [New cell biology research on the development of bronchial cancer].
Lorenz J
Internist (Berl); 1994 Aug; 35(8):692-9. PubMed ID: 7960549
[No Abstract] [Full Text] [Related]
10. [Molecular basis of cancer].
Meza-Junco J; Montaño-Loza A; Aguayo-González A
Rev Invest Clin; 2006; 58(1):56-70. PubMed ID: 16789600
[TBL] [Abstract][Full Text] [Related]
11. [Molecular (de)regulation and cancer: new therapeutic strategies].
Boulukos KE; Carlotti F; Pognonec P
Bull Cancer; 2001 Apr; 88(4):363-8. PubMed ID: 11371370
[TBL] [Abstract][Full Text] [Related]
12. p53: 25 years of research and more questions to answer.
Bourdon JC; Laurenzi VD; Melino G; Lane D
Cell Death Differ; 2003 Apr; 10(4):397-9. PubMed ID: 12719714
[No Abstract] [Full Text] [Related]
13. [The role of glycosphingolipids in the expression of neoplastic phenotype. I. The role of glycosphingolipids in cell adhesion and regulation of cell growth].
Ugorski M
Postepy Hig Med Dosw; 1991; 45(6):385-403. PubMed ID: 1813881
[No Abstract] [Full Text] [Related]
14. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
Nakamura J; Aoyagi S; Nanchi I; Nakatsuka S; Hirata E; Shibata S; Fukuda M; Yamamoto Y; Fukuda I; Tatsumi N; Ueda T; Fujiki F; Nomura M; Nishida S; Shirakata T; Hosen N; Tsuboi A; Oka Y; Nezu R; Mori M; Doki Y; Aozasa K; Sugiyama H; Oji Y
Int J Oncol; 2009 May; 34(5):1181-9. PubMed ID: 19360331
[TBL] [Abstract][Full Text] [Related]
15. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
16. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
[TBL] [Abstract][Full Text] [Related]
19. [Cell proliferation, dysplasia, hyperplasia and carcinogenesis].
Thiefin G
Gastroenterol Clin Biol; 1990; 14(12 ( Pt 2)):17D-19D. PubMed ID: 2073991
[No Abstract] [Full Text] [Related]
20. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
